<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01263964</url>
  </required_header>
  <id_info>
    <org_study_id>EA4/118/10</org_study_id>
    <secondary_id>01 EO 0801</secondary_id>
    <nct_id>NCT01263964</nct_id>
  </id_info>
  <brief_title>Troponin Elevation in Acute Ischemic Stroke (TRELAS)</brief_title>
  <acronym>TRELAS</acronym>
  <official_title>Troponin Elevation in Acute Ischemic Stroke (TRELAS) - a Prospective Study on the Frequency and Correlation to Coronary Artery Disease and to Stroke Localisation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of the prospective observational trial TRELAS (TRoponin ELevation in
      Acute ischemic Stroke) is to elucidate the underlying pathomechanism of cTnT elevation in
      acute ischemic stroke. Consecutive patients with acute ischemic stroke admitted to the
      Department of Neurology Campus Benjamin Franklin of the university hospital Charité will be
      screened for cTnT elevations suggestive of myocardial infarction (&gt;0,05 µg/l). Patients with
      increased troponin will undergo diagnostic coronary angiography within 72 hours. Diagnostic
      findings of coronary angiographies taken out in age- and gender-matched patients presenting
      with NSTE-ACS (Non-ST-Elevation Acute Coronary Syndrome) to the Division of Cardiology will
      serve as a control. The primary endpoint of the study will be the occurrence of culprit
      lesions indicating focal cardiac damage on the basis of an acute CAD.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of the prospective observational trial TRELAS (TRoponin ELevation in
      Acute ischemic Stroke) is to elucidate the underlying pathomechanism of cTnT elevation in
      acute ischemic stroke in order to give guidance for clinical practise. All consecutive
      patients with acute MRI- or CT-confirmed ischemic stroke admitting within 72 hours after
      symptom onset to the Department of Neurology Campus Benjamin Franklin of the university
      hospital of the Charité will be screened for cTnT elevations suggestive of myocardial
      infarction (&gt;0,05 µg/l) on admission and day 2. Patients with increased troponin will undergo
      diagnostic coronary angiography within 72 hours. Diagnostic findings of coronary
      angiographies taken out in age- and gender-matched patients presenting with NSTE-ACS
      (Non-ST-Elevation Acute Coronary Syndrome) to the Division of Cardiology will serve as a
      control. The primary endpoint of the study will be the occurrence of angiographic culprit
      lesions indicating focal cardiac damage on the basis of an acute CAD. Secondary endpoints
      will be the localisation of stroke in the cerebral imaging and ventriculographic findings of
      wall motion abnormalities suggestive of neurally mediated global cardiac dysfunction.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>culprit lesion on coronary angiogram</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>transient apical ballooning on levocardiogram</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stroke localization</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">58</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>stroke, troponin elevation</arm_group_label>
    <description>Patients with stroke (proven by cerebral imaging) and troponin elevation undergoing coronary angiogram</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-stemi (controll group)</arm_group_label>
    <description>Patients with troponin elevation suggesting non-stemi undergoing coronary angiogram</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>coronary angiogram</intervention_name>
    <description>coronary angiogram</description>
    <arm_group_label>stroke, troponin elevation</arm_group_label>
    <arm_group_label>non-stemi (controll group)</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Biomarkers indicating myocardial or neuronal damage
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted because acute ischemic stroke and additional troponin-elevation(cases) or
        non-stemi (controlls)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Acute ischemic stroke, confirmed by cerebral MRI or CT, respectively

          2. Inclusion within ≤ 72 hours after symptom onset

          3. hsTroponin T &gt;0,05 µg/l

        Exclusion Criteria:

          1. Renal insufficiency (creatinine ≥1,2 mg/dl)

          2. Limited life expectancy or mRS ≥ 4 prior to stroke event leading to hospital admission

          3. Contraindications for the coronary angiography

          4. Age &lt; 18 years

          5. Pregnancy

          6. Patient unwilling or unable to give informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthias Endres, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Charite Universitätsmedizin-Berlin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Charite Campus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charite, Campus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2010</study_first_submitted>
  <study_first_submitted_qc>December 20, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 21, 2010</study_first_posted>
  <last_update_submitted>July 18, 2014</last_update_submitted>
  <last_update_submitted_qc>July 18, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 21, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Christian Nolte</investigator_full_name>
    <investigator_title>PD Dr.med.</investigator_title>
  </responsible_party>
  <keyword>ischemic stroke</keyword>
  <keyword>troponin elevation</keyword>
  <keyword>transient apical ballooning</keyword>
  <keyword>acute coronary syndrome</keyword>
  <keyword>troponin elevation,</keyword>
  <keyword>culprit lesion on coronary angiogram,</keyword>
  <keyword>troponin elevation and stroke localisation (temporal lobe?)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

